Assessment of the Effectiveness of Local Ablathermy Radio Frequency (RF) Bronchial Tumors Primitive Stage IA Non-surgical Patients. Phase II Multicenter National
Lung tumors of non-small cell stage 1A are usually treated surgically but many patients are
not operable because of their condition or respiratory problems associated with it.
The treatment is then suggested that local radiotherapy is conventionally carried out in
split mode for 6 weeks at a dose of 60-65 Gy irradiation mode This exposes the patient to
complications, including post-radiation pneumonitis.
This can be problematic in patients with respiratory failure for which surgical treatment
has been challenged. Radiofrequency pulmonary developed as a therapeutic alternative, it has
the advantage of being performed in a session with less toxicity in the lung parenchyma
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Evaluation of the effectiveness of local ablathermy radiofrequency (RF) lung tumors primitive stage IA non-surgical patients. The effectiveness will be evaluated in terms of local control rate at 1 year
Evaluation of the effectiveness of local ablathermy radiofrequency (RF) lung tumors primitive stage IA non-surgical patients. The effectiveness will be evaluated in terms of local control rate at 1 year
07/2011 (1 year)
No
Jean PALUSSIERE, MD
Study Chair
Institut Bergonié
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
IB2008-34
NCT01841060
November 2008
December 2011
Name | Location |
---|